Attention Deficit Study In Healthy Children Can Proceed Under Certain Conditions, Cmte. Says
This article was originally published in The Pink Sheet Daily
Executive Summary
NIH proposal to administer dextroamphetamine to healthy children represents only a slightly greater than minimal risk to study participants, FDA's Pediatric Ethics Subcommittee says. The Pediatric Advisory Committee will review the recommendations Sept. 15.